Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Debate Moves Forward; Kennedy Sees Bill As “Down Payment”

Executive Summary

The Medicare legislation pending in the Senate is best viewed as a "down payment" on a more comprehensive prescription drug benefit, Sen. Edward Kennedy (D-Mass.) declared during the opening of floor debate June 16

You may also be interested in...



Merck Looks Past Medicare: Next Up, Covering The Uninsured

Merck is preparing for what it believes should be the next big health care policy debate in Washington after Medicare Rx legislation is enacted: health care coverage for the uninsured

Merck Looks Past Medicare: Next Up, Covering The Uninsured

Merck is preparing for what it believes should be the next big health care policy debate in Washington after Medicare Rx legislation is enacted: health care coverage for the uninsured

Medicare Rx Law Would Fundamentally Change, Not End, Drug Pricing Debate

A House proposal to fund federal cost-effectiveness trials of pharmaceuticals may be a sign of things to come if the Medicare prescription drug legislation is enacted this year

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042010

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel